Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy.

Merit Medical has enrolled the first patient in the PREEMIE study of the Bloom Micro Occluder System, aimed at treating PDA.

Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.

In a significant advancement for regional pediatric cardiac care, Shri Mata Vaishno Devi Narayana Superspeciality Hospital ...

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infantsSOUTH JORDAN, Utah, March 10, 2025 ...

On a sunny Friday, groups chat at wiry tables outside Panama Bay Coffee in downtown Livermore. Across the road, longstanding ...

Squirt, an 11-day-old ram lamb, received a lifesaving heart procedure by Oregon State University veterinarians, likely making it a world first.

has successfully performed five closed-heart surgeries - free of charge — to correct Patent Ductus Arteriosus (PDA), a congenital heart defect. Every year, UHI performs over 100 PDA operations ...

Kate Middleton and Prince William posted a photo of themselves sharing a romantic PDA moment in a rare Valentine's Day post on social media on Friday, Feb. 14.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter ...

A special night, beautiful people, a glamorous setting … how could you not fall in love? Though the highly coveted Oscars’ ...

Merit Medical Systems announced today that investigators enrolled the first patient in a study of its Bloom micro occluder ...